NCT07009210 · Mayo Clinic
AI Assisted Personalized Legacy Program (Reflections: My Story) for Patients With Serious Illness
What this study is about
The purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the AI Assisted Personalized Legacy Program intervention to patients with serious illness.
View original scientific description
The purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the AI Assisted Personalized Legacy Program intervention to patients with serious illness.
Interventions
BEHAVIORAL
AI Assisted Personalized Legacy Program
AI Assisted Personalized Legacy Program will be facilitated by a clinician trained in legacy work.
Primary outcome measures
Feasibility Number
Time frame: 2 years
Study feasibility will be measured by the number of participants who enrolled and finished the study.
Acceptability
Time frame: 5-10 days post-delivery of the final legacy document
Acceptability, as measured by the 7-item Was it Worth It (WIWI Questionnaire).The questions are answered as either "yes, no, or uncertain," overall perception of quality of life change, overall perception of study experience, one open-ended feedback question, and an option to talk with someone about concerns. Positive responses indicate acceptability. Results are reported as individual items.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- for patients:
- Age ≥18 years
- English fluency
- Provide informed consent
- Ability to complete questionnaire(s) by themselves or with assistance
Exclusion criteria
- Other psychological co-morbidities such as untreated schizophrenia, bipolar disease
- Recent suicide attempt or psychiatric illness severe enough that hospitalization has been necessary in last 6 months
- Active delirium
- Advanced dementia
- Participation in concurrent legacy offerings through the palliative care clinic
Where
- Phoenix, Arizona
- Rochester, Minnesota
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jun 17, 2026 · Source of record for eligibility and locations